Hadassah Medical Center is an Israeli medical organization established in 1934 that operates two university hospitals at Ein Kerem and Mount Scopus in Jerusalem as well as schools of medicine, dentistry, nursing, and pharmacology affiliated with the Hebrew University of Jerusalem.

There are 1,029 (more than) beds in Hadassah University Hospital - Ein Kerem.

During the past decade, Hadassah University Hospital - Ein Kerem conducted 69 clinical trials. In the 10-year time frame, 69 clinical trials started and 33 clinical trials were completed, i.e. on average, 47.8% percent of trials that started reached the finish line to date. In the past 5 years, 43 clinical trials started and 23 clinical trials were completed. i.e. 53.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hadassah University Hospital - Ein Kerem" #1 sponsor was "Bayer" with 14 trials, followed by "Hoffmann-La Roche" with 13 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 4 trials sponsored, "Gilead Sciences" with 4 trials sponsored and "Janssen Research & Development, LLC" with 4 trials sponsored. Other sponsors include 47 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hadassah University Hospital - Ein Kerem" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 4 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Basilea Pharmaceutica International Ltd" with 2 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 2 trials as a collaborator and "PRA Health Sciences" with 2 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Hadassah University Hospital - Ein Kerem" are "Ulcerative Colitis" (4 trials), "Breast Cancer" (3 trials), "Multiple Myeloma" (3 trials), "Aspergillosis" (2 trials) and "Chronic Kidney Disease" (2 trials). Many other conditions were trialed in "Hadassah University Hospital - Ein Kerem" in a lesser frequency.

Most popular intervention types in "Hadassah University Hospital - Ein Kerem" are "Drug" (81 trials), "Other" (10 trials), "Biological" (7 trials), "Radiation" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (31 trials), "Dexamethasone" (4 trials), "Paclitaxel" (4 trials), "Bortezomib" (3 trials) and "Carboplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hadassah University Hospital - Ein Kerem" are 84 trials for "All" genders, 4 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Hadassah University Hospital - Ein Kerem". 1 are not yet recruiting, 24 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Hadassah University Hospital - Ein Kerem, 1 suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Hadassah University Hospital - Ein Kerem, 5 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 63 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".